Literature DB >> 23521761

Lymph node ratio predicts local recurrence for periampullary tumours.

Sung Ryol Lee1, Hyung Ook Kim, Yong Lai Park, Jun Ho Shin.   

Abstract

BACKGROUND: To better define the prognostic role of nodal disease, evaluation of metastatic lymph node ratio (MLR) has been performed, and this method has recently gained prominence in various gastrointestinal cancers. The present study attempts to identify prognostic factors and evaluate the independent prognostic influence of MLR in patients who have undergone curative pancreaticoduodenectomy.
METHODS: In our institution within the study period, 111 patients received curative pancreaticoduodenectomy for periampullary cancers. Clinicopathologic data were collected and MLR was calculated for each of the patients. Patients were then divided into four groups based on MLR value: MLR 1 = 0; MLR 2 = 0.01-0.2; MLR 3 0.21-0.4; and MLR 4 >0.4.
RESULTS: Increasing MLR correlates with high recurrence rate and lower overall survival (OS) with significance (P < 0.001, P < 0.001). The recurrent group showed significantly lower OS than the non-recurrent group (P < 0.001). In the multivariate analysis for recurrence, MLR was identified as the only independent prognostic factor (P < 0.001).
CONCLUSIONS: The simple and easily obtainable MLR is well qualified as a prognostic factor in patients who undergo curatively radical resection for periampullary cancer. Furthermore, MLR can overcome the limitations of evaluation of lymph nodes status, allowing it to be used as a potential prognostic factor.
© 2013 The Authors. ANZ Journal of Surgery © 2013 Royal Australasian College of Surgeons.

Entities:  

Keywords:  curative pancreaticoduodenectomy; metastatic lymph node ratio; periampullary cancer; prognostic factor

Mesh:

Year:  2013        PMID: 23521761     DOI: 10.1111/ans.12129

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  3 in total

1.  Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.

Authors:  Serdar Balci; Olca Basturk; Burcu Saka; Pelin Bagci; Lauren M Postlewait; Takuma Tajiri; Kee-Taek Jang; Nobuyuki Ohike; Grace E Kim; Alyssa Krasinskas; Hyejeong Choi; Juan M Sarmiento; David A Kooby; Bassel F El-Rayes; Jessica H Knight; Michael Goodman; Gizem Akkas; Michelle D Reid; Shishir K Maithel; Volkan Adsay
Journal:  Ann Surg Oncol       Date:  2015-03-18       Impact factor: 5.344

2.  Impact of lymph node staging systems in predicting outcome in patients with ampullary cancer.

Authors:  Sundeep Singh Saluja; Pramod Kumar Mishra; Shashi Kiran; Harsh J Shah; Sandip Chandrasekar; Mohammed Nayeem; Aditya Sharma; Vaibhav Kumar Varshney
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-11-30

3.  Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer.

Authors:  Michael Feretis; Tengyao Wang; Satheesh Iype; Adam Duckworth; Rebecca Brais; Bristi Basu; Neville V Jamieson; Emmanuel Huguet; Anita Balakrishnan; Asif Jah; Raaj K Praseedom; Simon J Harper; Siong-Seng Liau
Journal:  Pancreas       Date:  2017 Nov/Dec       Impact factor: 3.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.